Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL)

NCT01096992 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Bendamustine
DRUG: Fludarabine
DRUG: Rituximab

Sponsor

M.D. Anderson Cancer Center